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Abstract: Introduction: There is a controversy regarding accuracy of neutrophil gelatinase-associated lipocalin (NGAL)
and Cystatin C in early detection of acute kidney injury (AKI). The present study aimed to compare the diag-
nostic value of two biomarkers in this regard. Methods: In the present diagnostic accuracy study, all children
between the ages of 1 month to 14 years were entered. Pediatric Risk, Injury Failure, Loss, End-stage renal dis-
ease (pRIFLE) criteria was used for identification of children with AKI as the reference test. Blood samples were
taken from all patients at baseline and 48 hours after admission to assess serum creatinine and Cystatin C level.
In addition, a urine sample was obtained within 6 hours of admission in order to measure NGAL level. In the
end, area under the receiving operating characteristics (ROC) curve, sensitivity, and specificity of urine NGAL
(uNGAL) and Cystatin C in early detection of AKI were compared. Results: Data from 96 children with the mean
age of 27.31±36.24 months were entered (56.25% girls). Area under the ROC curve of uNGAL level in diagnosis
of AKI in children was 0.91 (95% CI: 0.80 to 1.00) and area under the ROC of Cystatin C was 0.90 (95% CI: 0.77 to
1.00). Both tests had the same value in diagnosis of AKI (p=0.89). The best cut-off point of uNGAL for diagnosing
AKI was 125 mg/L. uNGAL had a sensitivity and specificity of 0.92 (0.62 to 0.99) and 0.69 (0.57 to 0.78), respec-
tively. The best cut-off point of serum Cystatin C level was 0.4 mg/L. Cystatin C had a sensitivity and specificity
of 0.92 (0.62 to 0.99) and 0.64 (0.52 to 0.74), respectively. Conclusion: The present study showed that uNGAL
level has the same value as serum Cystatin C level in early diagnosis of AKI.
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cute kidney injury (AKI) is considered an important
issue that if not promptly managed can lead to se-
rious complications such as chronic kidney disease,
end-stage renal diseases and even death (1-3). Recent stud-
ies show that preventive strategies can significantly reduce
the burden of the disease (4) and early diagnosis and treat-
ment of AKI can significantly decrease medical costs. Unfor-
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tunately kidney diseases are asymptomatic most of the time
and disease manifestations do not occur until a large amount
of renal tissue is destroyed (5). Hence, the best suggestion is
that nephrologists and physicians of other specialties begin
to comprehend the importance of early diagnosis of kidney
disease. Several diagnostic methods are introduced for iden-
tification of children with AKI, but none of them could accu-
rately predict the outcome of disease in the initial stages (6).
Over the past decade, many studies have shown that multiple
serum and urine biomarkers are useful for early detection of
kidney injury and have a better prognostic role than previous
diagnostic tools (7-9). After three meta-analyses we reached
a conclusion indicating that biomarkers such as neutrophil
gelatinase-associated lipocalin (NGAL) and Cystatin C are ac-
curate predictors of AKI (10-12). However, it is yet to be stud-
ied which one of these biomarkers and their sources (serum
or urine) have greater value in prediction of AKI. A meta-
analysis reported that serum Cystatin C has a greater diag-
nostic value in detection of AKI in children and adolescents
than its urine level (10). Existing evidence regarding NGAL is
however inconclusive and further research needs to be car-
ried out (13-15). The present study aimed to assess the value
of urinary NGAL (uNGAL) and serum Cystatin C in early di-
agnosis of hospitalized children with AKI.
2. Methods
2.1. Study design and setting
In the present diagnostic accuracy study, the value of urine
NGAL in early detection of pediatric AKI was assessed. All
children brought to Children’s Medical Center of Tehran,
Iran, between 2015 and 2016 were entered in a prospective
manner. The protocol of the present study was approved by
the Ethics Committee of Tehran University of Medical Sci-
ences and all researchers adhered to the principles of the
Helsinki declaration during the study period. Additionally, a
consent form was obtained from patients or their parents.
2.2. Participants
The study population of the present study consisted of all
children between the ages of 1 month and 14 years, who
were suspected to AKI according to their in-charge physi-
cian’s opinion. Exclusion criteria were children with chronic
kidney disease, need for renal replacement therapy and those
not giving consent. Convenience sampling was used in the
present study.
2.3. Test methods
Blood samples were taken from all patients on admission and
48 hours after admission and were sent to the laboratory of
Children’s Medical Center in order to assess serum creatinine
and Cystatin C level. Creatinine measurement was done us-
ing Jaffe method, a spectrophotometry kit and a Hitachi 717
device. Additionally, serum Cystatin C was measured using
Cystatin C ELISA Kit from BioPorto Diagnostic of Denmark
using Sandwich ELISA method. Glomerular filtration rate
(GFR) was calculated based on Cystatin C formula (16).
A urine sample was obtained within 6 hours of admission and
was stored in -80◦c after centrifuge. Measurement of uNGAL
was done using an NGAL ELISA kit from BioPorto Diagnos-
tics, Denmark using Sandwich ELISA method. In addition,
the laboratory and technicians who entered data were not
aware of the AKI status of patients. Index test was assessed
in a blind manner as uNGAL measurement was performed
before GFR calculation.
2.4. Outcome
AKI was considered as the endpoint of the study. Pediatric
Risk, Injury Failure, Loss, End-stage renal disease (pRIFLE)
criteria was used for identification of children with AKI as the
reference test (17). Therefore, a decrease in estimated creati-
nine clearance by at least 25% from baseline within 48 hours
after admission was considered the definition of AKI.
2.5. Statistical Analysis
The required sample size was estimated based on the sug-
gested method of Hajian-Tilaki (18). A sensitivity of 93% for
uNGAL in diagnosis of AKI and a minimum marginal error of
0.1 (19) were considered in calculating the sample size hence,
91 patients were required. In the end, data from 96 patients
were entered and analyzed. Data were analyzed using STATA
11.0. Patients were divided to two groups of AKI and no-AKI
based on their GFR level within 48 hours of admission. At the
end, area under the receiving operating characteristics (ROC)
curve, sensitivity, specificity, positive predictive value (PPV),
negative predictive value (NPV), positive and negative likeli-
hood ratios of uNGAL and Cystatin C were calculated in order
to assess their discriminatory power with a 95% confidence
interval (CI). Areas under the curve of the two biomarkers
were compared using the method suggested by Cleves and
Rock (20). General calibration was assessed by drawing cal-
ibration plot, which showed that the perfect calibration was
the reference line with an intercept of zero and slope of 1.
As the slope and intercept of calibration plot of models be-
come closer to 1 and zero, respectively, they will be consid-
ered more perfect in prediction of AKI. Additionally, overall
performance was calculated using Brier score in order to as-
sess the predictive accuracy and predictive reliability. A p
value of less than 0.05 was considered significant in all anal-
yses.
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Table 1: Summary of demographic, baseline, and laboratory values based on outcome
Variable No-AKI (n = 83) AKI (n = 13) Total (n = 96) P
Sex (n, %)
Boy 47 (56.63) 7 (53.85) 54 (56.25) 0.85
Girl 36 (43.37) 6 (46.15) 42 (43.75)
Age (month) 28.66±37.58 18.69±25.58 27.31±36.24 0.64*
Etiology of AKI
Pneumonia 7 (8.43) 0 (0.0) 7 (7.29) 0.24#
Cardiac diseases 14 (16.87) 3 (23.08) 17 (17.71)
Trauma 3 (3.61) 0 (0.0) 3 (3.13)
Sepsis 4 (4.82) 2 (15.38) 6 (6.25)
Urologic disorders 21 (25.30) 2 (15.38) 23 (23.96)
Pulmonary 14 (16.87) 2 (15.38) 16 (16.67)
Liver diseases 6 (7.23) 2 (15.38) 8 (8.33)
Metabolic disorders 3 (3.61) 2 (15.38) 5 (5.21)
Other 11 (13.25) 0 (0.0) 11 (11.46)
Height (cm) 76.48±25.30 72.08±21.55 75.88±24.75 0.63*
Cystatin C on admission
(mg/L)
0.35±0.45 1.97±1.10 0.57±0.80 < 0.0001*
uNGAL (mg/L) 168.59±284.52 1929.92±3957.54 407.10±1554.12 < 0.0001*
Creatinine (mg/L)
Baseline 0.48±0.16 0.49±0.16 0.49±0.16 0.61*
48 hours 0.44±0.14 1.08±0.36 0.53±0.28 < 0.0001*
eCCI (ml/min/ 1.73 m2)
Baseline 91.36±37.24 34.46±10.84 83.66±39.94 0.61*
48 hours 91.36±37.24 34.46±10.84 83.66±39.94 < 0.0001*
AKI: acute kidney injury; eCCI: estimated creatinine clearance by Cystatin C equation;
uNGAL: urinary neutrophil gelatinase-associated lipocalin. *, based on Mann-Whitney U test;
#, based on Fisher’s exact test.
Table 2: Screening performance characteristics of urinary neutrophil gelatinase-associated lipocalin (uNGAL) and Cystatin C in detection of
acute kidney injury (AKI)
Performance Cystatin C uNGAL
Cut off 0.4 mg/L 125 mg/L
True positive 12 12
True negative 53 57
False positive 30 26
False negative 1 1
Sensitivity 0.92 (0.62 to 0.99) 0.92 (0.62 to 0.99)
Specificity 0.64 (0.52 to 0.74) 0.69 (0.57 to 0.78)
Positive predictive value 0.29 (0.16 to 0.45) 0.32 (0.18 to 0.49)
Negative predictive value 0.98 (0.89 to 1.0) 0.98 (0.89 to 1.0)
Positive likelihood ratio 2.55 (1.84 to 3.54) 2.95 (2.07 to 4.20)
Negative likelihood ratio 0.12 (0.02 to 0.80) 0.11 (0.02 to 0.74)
*, Data are presented as estimated value and 95% confidence interval.
3. Results
3.1. Baseline characteristics
Data from 96 children with the average age of 27.31±36.24
months (ranging from 1 month to 156 months) were en-
tered (56.25% boys). Urologic problems (26.96%) were the
most common etiology for AKI. Due to pRIFLE criteria, 13
cases (13.54%) of AKI were identified. The uNGAL level in
AKI group (1929.92±3957.54) was significantly higher than
no-AKI group (168.59±284.52) with a p value of less than
0.0001. Similar results were observed regarding Cystatin C
levels (1.97±1.10 vs. 0.35±0.45; p < 0.0001) (table 1).
Area under the ROC of urine NGAL level in diagnosis of AKI
in children was 0.91 (95% CI: 0.80 to 1.00) and area under
the ROC of Cystatin C was 0.90 (95% CI: 0.77 to 1.00). Both
tests had the same value in diagnosis of AKI (p=0.89) (figure
1). Both biomarkers had appropriate calibration levels. The
slope of calibration line for uNGAL and Cystatin C were 1.02
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Figure 1: Comparison of the areas under the receiver operating
characteristics (ROC) curve of urinary neutrophil gelatinase associ-
ated lipocalin (uNGAL) and serum Cystatin C level in diagnosis of
acute kidney injury in children within 48 hours of admission.
and 1.001, respectively. The calculated intercept of the men-
tioned biomarkers were -0.006 and -0.0006, respectively. Ad-
ditionally, Brier score of uNGAL and Cystatin C were 0.07 and
0.08, respectively, which showed good overall performance
of both biomarkers in diagnosis of AKI in children (figure 2).
The best cut-off point of uNGAL for diagnosis AKI was 125
mg/L. uNGAL had a sensitivity and specificity of 0.92 and
0.69, respectively at this level. uNGAL level had a PPV and
NPV of 0.32 and 0.98, respectively. The best cut-off point of
serum Cystatin C level was 0.4 mg/L. Cystatin C had a sensi-
tivity and specificity of 0.92 and 0.64, respectively at the men-
tioned cut-off point. Additionally, Cystatin C had a PPV and
NPV of 0.28 and 0.98, respectively (table 2).
4. Discussion
The present study showed that uNGAL and serum Cystatin
C level are reliable biomarkers for early detection of pedi-
atric AKI. Level of these biomarkers measured early after in-
jury can identify AKI much sooner than conventional meth-
ods. NGAL is a 20 kDa protein expressed in renal tubules
which is released into the urine in case of acute or chronic
kidney injury. Therefore, uNGAL level might reflect kidney
injury. Faster increase in uNGAL level compared to serum
creatinine level in response to AKI is one of its benefits over
creatinine. However, some biomarkers such as serum crea-
tinine level indicate renal function and are indirectly indica-
tive of AKI (21). In other words, GFR should decrease to a
certain level in order to disturb creatinine clearance and in-
crease its serum level, which is required for diagnosis of AKI.
However, NGAL level increases in urine in response to kid-
ney injury; hence, it can be a better marker of the severity of
AKI (22). In a meta-analysis of 37 studies by researchers of
the present study, it was reported that assessing uNGAL level
within the first 6 hours of admission can accurately predict
the incidence of acute kidney injury in children in the first
48 hours (12). Similar results were found in another meta-
analysis on serum NGAL level. However, the best window
period for measuring serum NGAL level was reported to be
within the first 12 hours of admission (11). Due to the men-
tioned findings, uNGAL level seems to have a better perfor-
mance in prediction of AKI.
Cystatin C is another biomarker, the predictive value of which
was proven in the present study. Similarly, a meta-analysis
showed that serum Cystatin C level has a reasonably good
value in predicting AKI in children. Additionally, serum Cys-
tatin C level has a greater value compared to its urine level
(10). Hence, serum Cystatin C level was used in the present
study. For the first time, the present study showed that uN-
GAL and serum Cystatin C level have similar values in predic-
tion of AKI in children.
5. Limitation
Small sample size is one of the limitations of the present
study. In the present small sized study, patients brought to an
individual center were assessed and selection bias might be
present as convenience sampling was used. Short follow-up
period (48 hours) was another limitation of this study. Addi-
tionally, misclassifications might be present as a small num-
ber of patients show signs and symptoms of AKI (based on
pRIFLE criteria) after the first 48 hours (during the first week
of admission or even later).
6. Conclusion
The present study showed that both uNGAL and serum Cys-
tatin C level are highly valuable predictors of AKI within
the first hours of admission. In other words, level of these
biomarkers measured early after injury can identify AKI
much sooner than conventional methods. Additionally, uN-
GAL seems to be a better biomarker in children and adoles-
cents as its assessment is less invasive than assessing serum
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Figure 2: Calibration plot of urinary neutrophil gelatinase-associated lipocalin (uNGAL) and Cystatin C in detection of acute kidney injury
(AKI).
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